Atorvastatin Calcium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Conditions: Episodic Migraine Interventions: Drug: Atorvastatin 40mg; Drug: Placebo; Drug: Atorvastatin 20mg Sponsors: St. Olavs Hospital; Haukeland University Hospital; Oslo University Hospital; University Hospital of North Norway; University Hospital, Akershus; Ullevaal University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Conditions: Hyperlipidemias Interventions: Drug: SGB-3403; Other: Atorvastatin; Other: Placebo Sponsors: Suzhou Sanegene Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

ATORvastatin in Pulmonary TUBerculosis
Conditions: Pulmonary Tuberculosis; Tuberculosis; Koch ' s Disease Interventions: Drug: Atorvastatin 20mg; Drug: Atorvastatin 40mg; Drug: Atorvastatin 60mg Sponsors: Obafemi Awolowo University Teaching Hospital; Open Philanthropy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Conditions: Healthy Volunteers Interventions: Drug: Atorvastatin; Drug: ALG-055009; Drug: Rosuvastatin Sponsors: Aligos Therapeutics Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma
Conditions: Clinical Stage IIA Cutaneous Melanoma AJCC v8 Interventions: Drug: Atorvastatin; Drug: Placebo Administration; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Other: Electronic Health Record Review Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Kuni Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Conditions: Coronary Artery Disease; Nephropathy; Toxic, Drugs Interventions: Drug: Atorvastatin 80mg; Drug: N-acetyl cysteine; Other: Normal Saline Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
Conditions: Acute Metabolic Effects of Evolocumab and Atorvastatin Interventions: Drug: Evolocumab Sponsors: Region Stockholm; Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Interventions: Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); Sponsors: Peking University People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Statins in Patients With Spontaneous Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: Atorvastatin; Drug: Rosuvastatin; Other: No drugs Sponsors: Pomeranian Medical University Szczecin Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Conditions: Healthy Volunteers Interventions: Drug: Obicetrapib; Drug: Atorvastatin Calcium; Drug: Rosuvastatin Calcium Sponsors: NewAmsterdam Pharma; Pharma Medica Research, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials

Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
Conditions: Intracranial Atherosclerosis; Atherosclerotic Plaque; Stenosis Interventions: Drug: Alirocumab; Drug: Atorvastatin Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Condition: Mi Q Wave Interventions: Device: Turbox CRP kit; Drug: rosuvastatin 20 mg,; Drug: atorvastatin 40 mg Sponsor: Rawalpindi Medical College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Conditions: Mi Q Wave Interventions: Device: Turbox CRP kit; Drug: rosuvastatin 20 mg,; Drug: atorvastatin 40 mg Sponsors: Rawalpindi Medical College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials